Bridging Science and
Execution in Preclinical In
Vivo Development

Independent coordination for scientifically

robust and operationally aligned preclinical

studies across Europe.

Bridging Science and Strategy
Our Key Focus Areas

Coordinating science, strategy, and compliance to accelerate

preclinical success across Europe.

Preclinical Study
Coordination

Structured multi-site project execution

DE & NL Regulatory Alignment

Expertise in Paragraph 44 and Article 9 licensing

CRO + Academic Integration

Access to trusted European scientific partners

Integrated Reporting

Consolidated data insights for investors and publications

About the Company

InVivoBridge is an independent consulting and coordination partner supporting early-stage biotech companies developing vaccines, biologics, and anti-infective therapies.


We specialize in connecting science with strategy helping biotech teams design, plan, and coordinate preclinical in vivo studies through a trusted European network of academic and CRO partners.

Unlike contract research organizations (CROs), InVivoBridge does not perform laboratory experiments.


Instead, we bring scientific and operational alignment to every project ensuring that the right partners, models, and regulatory frameworks are in place before execution begins.

Our mission is to bridge communication gaps between scientists, partners, and regulators, accelerating decision-making and improving the quality of preclinical outcomes.


Why InVivoBridge

InVivoBridge simplifies one of the hardest parts of biotech innovation — coordinating complex in vivo programs across partners and regulatory systems with precision and structure.

 
  1. Faster Execution Through Proactive Planning
 We anticipate challenges early, aligning models, partners, and licensing steps to prevent study delays.
  2. Independent Oversight — Not a CRO
 As an independent coordinator, we don’t run lab work — we ensure clear, unbiased communication between CROs, academics, and biotech teams.
  3. Access to Specialized Infection-Immunology Models
 Our European network provides validated infection and immunology models supporting vaccines, biologics, and antibody programs — without multiple partner contracts.
  4. Scientific Precision & Regulatory Clarity
 Every project follows EU Directive 2010/63, Paragraph 44 (Germany), and Article 9 (Netherlands) — ensuring compliance and scientific integrity throughout.



Testimonials Preview

 Client and partner feedback reflects the clarity and structure that InVivoBridge brings to preclinical coordination.
 Our collaborators value scientific precision, communication, and independent oversight.

“Dr. Kanwal brings structure and clarity to complex preclinical programs.”
 — CRO Partner, Germany

 
 

“Independent, structured, and deeply scientific — exactly what translational projects need.”
 — Academic Collaborator, Netherlands

Ready to Move Your Preclinical Studies Forward?

Let’s align science, strategy, and execution to accelerate your next in vivo program efficiently and compliantly across Europe.